GURU.Markets stock price, segment price, and overall market index valuation
The company's share price McKesson Corporation
McKesson is one of the "big three" pharmaceutical distributors in the United States. The company is a vital link in the drug supply chain from manufacturers to pharmacies and hospitals. Its stock reflects the stability and scale of this logistics business.
Share prices of companies in the market segment - Pharmacy
McKesson is one of the "big three" pharmaceutical distributors in the US, also with a medical IT solutions segment. We classify it as part of the Pharmacy sector, and the chart below reflects the dynamics of this low-margin, yet critically important industry.
Broad Market Index - GURU.Markets
McKesson is one of the largest distributors of pharmaceuticals and medical supplies in the United States. Its key role in the healthcare supply chain makes it a key component of the GURU.Markets index. The chart below represents the entire market. Find out how McKesson compares to it.
Change in the price of a company, segment, and market as a whole per day
MCK - Daily change in the company's share price McKesson Corporation
The daily price change for McKesson, a drug distributor, demonstrates its stability and responsiveness to healthcare trends. While the chart of these fluctuations is unspectacular, it is a critical component of the formulas on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Pharmacy
McKesson Corporation is one of the largest pharmaceutical distributors. This chart shows the average daily volatility of the healthcare sector. Comparing it to MCK, which operates on low margins but has huge turnover, helps understand its unique risk profile within the industry.
Daily change in the price of a broad market stock, index - GURU.Markets
McKesson is one of the largest distributors of pharmaceuticals and medical supplies in the United States. The healthcare sector is considered relatively defensive. The chart below shows general market fluctuations, which can be used to assess how the healthcare sector, represented by McKesson, is responding to economic challenges.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization McKesson Corporation
McKesson is one of the three giants in drug distribution in the US. Its business is the backbone of the entire healthcare system. The year-over-year stock price performance shown in the chart reflects its stability and key role in the pharmaceutical supply chain.
Annual dynamics of market capitalization of the market segment - Pharmacy
McKesson Corporation is one of the "big three" drug distributors in the United States. It's a business with low profit margins, but huge revenues and high stability. Its performance reflects overall healthcare spending growth, rather than the success of individual drugs, making it a barometer for the entire drug supply chain.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
McKesson is one of the "big three" pharmaceutical distributors in the US. Its business has very low margins but huge turnover, providing a stable cash flow. The company's growth reflects the state of the American healthcare system and is an example of a sustainable, albeit slow-growing, business.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization McKesson Corporation
For McKesson, a drug distribution giant, this chart demonstrates the stability and scale of its operations. Monthly price fluctuations reflect the volume of medications supplied to pharmacies and hospitals, drug pricing news, and general trends in the US healthcare sector.
Monthly dynamics of market capitalization of the market segment - Pharmacy
This chart illustrates the dynamics of the drug distribution sector, where McKesson is one of three dominant players in the US. Its steady growth reflects the continued demand for medications. It's a low-margin, yet huge and stable business.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
McKesson is one of the "big three" pharmaceutical distributors in the US and a provider of healthcare IT solutions. They are the lifeblood of American healthcare. The chart below shows market fluctuations, against which McKesson shares typically exhibit low volatility and defensive properties.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization McKesson Corporation
McKesson Corporation is one of the "big three" pharmaceutical distributors in the United States. Its weekly stock price reflects drug sales volumes, pricing trends, and its role in the healthcare supply chain. It's a stable but low-margin business.
Weekly dynamics of market capitalization of the market segment - Pharmacy
McKesson, as one of the largest drug distributors, is a barometer for the entire healthcare system. Its weekly performance reflects overall prescription drug sales. The chart compares its low-margin but stable business with more volatile biotech or insurance companies.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
McKesson is one of the largest pharmaceutical distributors in the US. It's a business with low margins but huge and stable revenues. The chart shows how this predictability makes McKesson shares less volatile than the overall market.
Market capitalization of the company, segment and market as a whole
MCK - Market capitalization of the company McKesson Corporation
McKesson's market capitalization reflects its key yet understated role in the US healthcare system. As one of the top three drug distributors, it is a vital link between manufacturers and pharmacies. Its stable price chart demonstrates how investors value this indispensability and the scale of its logistics network.
MCK - Share of the company's market capitalization McKesson Corporation within the market segment - Pharmacy
McKesson is one of the "big three" pharmaceutical distributors in the US, holding a huge market share. Its market capitalization reflects its critical role in the healthcare supply chain, ensuring the supply of medications to pharmacies and hospitals across the country.
Market capitalization of the market segment - Pharmacy
Below is a chart of the drug distribution sector's market capitalization. McKesson is one of the "big three" wholesalers that form an oligopoly in the US market. The size of this market reflects the enormous volume of drug sales. McKesson is a critical, albeit low-margin, link between manufacturers and pharmacies.
Market capitalization of all companies included in a broad market index - GURU.Markets
McKesson Corporation is one of the "Big Three" drug distributors in the United States. The company is a vital link between manufacturers and pharmacies. Its market capitalization reflects its scale and critical role in the healthcare supply chain.
Book value capitalization of the company, segment and market as a whole
MCK - Book value capitalization of the company McKesson Corporation
McKesson's book value is its massive and highly efficient distribution network: warehouses and vehicles that deliver drugs to pharmacies and hospitals across North America. This is the backbone of pharmaceutical logistics. The chart shows how this wholesale distributor manages its massive working capital and invests in its physical infrastructure.
MCK - Share of the company's book capitalization McKesson Corporation within the market segment - Pharmacy
Ferrari isn't just cars; it's a legend created in a very real and exclusive production facility. The chart shows the company's unique share of the automotive industry's assets. Its Maranello plant is more than just an assembly line, but a temple of engineering excellence where automotive masterpieces are born.
Market segment balance sheet capitalization - Pharmacy
McKesson is a pharmaceutical distributor. Compared to the capital-intensive healthcare industry, its model is logistical. The sector's asset chart reflects the value of hospitals and factories. McKesson, on the other hand, invests in gigantic, highly automated warehouses, serving as the "lifeblood" of the pharmaceutical industry.
Book value of all companies included in the broad market index - GURU.Markets
McKesson Corporation is one of the "big three" pharmaceutical distributors in the United States. Its assets lie in its massive, highly automated warehouses and logistics network, which ensures daily delivery of medications to pharmacies and hospitals across the country.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - McKesson Corporation
McKesson Corporation is a pharmaceutical distributor. Its valuation is only slightly above its book value (warehouse and inventory), reflecting the very low profitability of this business. The market appreciates its scale but does not expect significant growth.
Market to book capitalization ratio in a market segment - Pharmacy
McKesson Corporation is one of the "big three" pharmaceutical distributors in the US, serving as a vital link between drug manufacturers and pharmacies. This chart shows how the market values โโits key, yet low-margin, role in the healthcare system, typically resulting in a valuation close to its book value.
Market to book capitalization ratio for the market as a whole
McKesson Corporation is one of the largest pharmaceutical distributors in the US, as well as a provider of medical supplies and healthcare IT solutions. This chart shows the average market valuation. Against this backdrop, its valuation reflects its critical but low-margin role in the drug supply chain and the challenges associated with opioid lawsuits.
Debts of the company, segment and market as a whole
MCK - Company debts McKesson Corporation
For McKesson, one of the largest pharmaceutical distributors in the US, its debt policy reflects the low-margin yet scalable nature of its business. The company uses debt to manage its vast working capital and for strategic investments in healthcare technologies and services.
Market segment debts - Pharmacy
McKesson is one of the "big three" pharmaceutical distributors in the US. It's a business with huge revenues but very low profitability. Effective management of working capital and debt is critical to survival. This chart provides insight into the financial structure of the company, a key link in the healthcare system.
Market debt in general
McKesson Corporation is one of the three largest pharmaceutical distributors in the United States, serving as a key link between drug manufacturers and pharmacies. The business is characterized by very high turnover and low profitability. This total debt chart helps understand how McKesson manages its working capital on a massive scale.
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio McKesson Corporation
McKesson is one of the three largest pharmaceutical distributors in the US, operating with very low profit margins. This chart shows the wholesaler's financial structure. Debt is used to finance the massive working capital required to purchase and distribute drugs nationwide.
Market segment debt to market segment book capitalization - Pharmacy
McKesson is one of the "big three" pharmaceutical distributors in the US, playing a key role in the drug supply chain. It's a low-margin business with huge revenues. This chart shows how the company's debt policy reflects its operating model, relating it to the overall healthcare sector's market capitalization.
Debt to book value of all companies in the market
McKesson, a pharmaceutical distribution giant, operates in a business with huge revenues but low profitability. This requires effective working capital management. This chart compares its debt load to the average level for the entire economy, showing how its operating model affects its financial structure.
P/E of the company, segment and market as a whole
P/E - McKesson Corporation
This chart shows the valuation of McKesson, one of the largest drug distributors in the US. Its P/E ratio is traditionally very low. This is due to the nature of its business: the company operates at enormous volumes but with extremely low profit margins. Investors view it as a low-margin but stable wholesaler.
P/E of the market segment - Pharmacy
McKesson Corporation is one of the "Big Three" pharmaceutical distributors in the United States. The company is a vital link in the drug supply chain from manufacturers to pharmacies and hospitals. This chart shows the average valuation for the healthcare sector, helping to understand how the market values โโMcKesson's low-margin, yet stable and scalable business.
P/E of the market as a whole
McKesson Corporation is one of the "big three" pharmaceutical distributors in the United States. The company is a vital, yet low-margin, link in the drug supply chain. Its business is characterized by stability and huge turnover. This sentiment chart helps assess how much investors value the predictability of this healthcare logistics giant.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company McKesson Corporation
McKesson Corporation is one of the largest pharmaceutical distributors in the US, connecting drug manufacturers with pharmacies and hospitals. This chart reflects expectations for the stability of the healthcare system. The company's valuation depends on the volume of drugs distributed and the efficiency of its vast logistics network.
Future (projected) P/E of the market segment - Pharmacy
McKesson is one of the "Big Three" pharmaceutical distributors in the US, serving as a critical link between drug manufacturers and pharmacies. This chart shows how the market values โโits stable, low-margin business. Comparing its profit forecasts to the sector reflects the premium it places on its indispensable role in the healthcare system.
Future (projected) P/E of the market as a whole
McKesson Corporation is one of the largest pharmaceutical distributors in the United States, connecting drug manufacturers with pharmacies and hospitals. It's a low-margin business with huge revenues. The company's services are vital, ensuring stability. Market sentiment has little impact on its operations.
Profit of the company, segment and market as a whole
Company profit McKesson Corporation
McKesson Corporation is one of the "big three" pharmaceutical distributors in the United States. The company is a critical link between drug manufacturers and pharmacies/hospitals. Its business is low-margin but has huge revenues. This chart illustrates the stability inherent in healthcare logistics.
Profit of companies in the market segment - Pharmacy
McKesson Corporation is one of the largest pharmaceutical distributors in the United States, as well as a provider of medical supplies and healthcare IT solutions. The company is a critical link in the drug supply chain. Its profitability, although low-margin, reflects the volume of drug consumption in the country and the effectiveness of the healthcare system.
Overall market profit
McKesson Corporation is one of the largest distributors of pharmaceutical products, medical supplies, and healthcare IT solutions in the United States. The company is a key link in the drug supply chain from manufacturers to pharmacies and hospitals. Its activities support the functioning of the entire healthcare system, and its supply volumes reflect the level of healthcare consumption in the country.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company McKesson Corporation
McKesson is one of the "big three" pharmaceutical distributors in the US. The company is a key link between drug manufacturers and pharmacies. This chart shows expectations of stable, albeit low-margin, profits from its huge volume of operations.
Future (predicted) profit of companies in the market segment - Pharmacy
McKesson Corporation is a leading distributor of pharmaceuticals and medical supplies in North America. The forecast chart reflects profit expectations for the healthcare sector. It allows one to assess the role of wholesale suppliers in the drug supply chain and the sustainability of their low-margin business model.
Future (predicted) profit of the market as a whole
The dynamics in this chart reflect expectations for one of the largest pharmaceutical distributors in the US. McKesson's profit forecast depends on drug sales volumes and stable, albeit tight, margins. The company plays a key role in the healthcare supply chain, connecting drug manufacturers with pharmacies and hospitals.
P/S of the company, segment and market as a whole
P/S - McKesson Corporation
McKesson is one of the "big three" pharmaceutical distributors in the US, supplying pharmacies and hospitals. This chart shows how investors value its enormous revenues against very low margins. The multiple reflects the stability of the business, which is a critical link in the healthcare supply chain.
P/S market segment - Pharmacy
McKesson Corporation is one of the largest pharmaceutical distributors in the US, as well as a supplier of medical supplies and healthcare IT solutions. This chart shows the average industry revenue estimate. It helps assess how investors perceive the company, which has a low-margin but stable and scalable business.
P/S of the market as a whole
McKesson Corporation is one of the "big three" pharmaceutical distributors in the US, supplying medications to pharmacies and hospitals. Its business is low-margin but has huge revenues. This chart, showing McKesson's average revenue estimate, helps understand how the market values โโits critical role in the healthcare supply chain.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company McKesson Corporation
McKesson is one of the "big three" pharmaceutical distributors in the US, a key link between drug manufacturers and pharmacies. The company's business is low-margin but boasts huge revenues. This chart shows how investors estimate future revenues, which depend on the total volume of prescription drug sales in the country.
Future (projected) P/S of the market segment - Pharmacy
McKesson Corporation is one of the "big three" pharmaceutical distributors in the US, a vital link between drug manufacturers and pharmacies. This chart shows how investors value this logistics giant. To what extent is its low-margin, yet massive, business valued for its stability?
Future (projected) P/S of the market as a whole
McKesson Corporation is one of the largest pharmaceutical distributors in the United States. The company is a key link between drug manufacturers and pharmacies/hospitals. Its revenue reflects overall drug spending in the country. Steady growth in this metric is an important part of the healthcare sector, whose prospects are reflected in this chart.
Sales of the company, segment and market as a whole
Company sales McKesson Corporation
McKesson Corporation is one of the "big three" pharmaceutical wholesale distributors in the United States. The company is a key link between drug manufacturers and pharmacies. This chart shows the enormous drug sales volumes that pass through its logistics network, reflecting healthcare costs.
Sales of companies in the market segment - Pharmacy
McKesson Corporation is one of the "Big Three" pharmaceutical distributors in the United States. The company is a vital link in the healthcare supply chain, delivering medications to pharmacies and hospitals. This chart shows overall sales in the sector, illustrating the vast size of the pharmaceutical market and the role distributors play in its functioning.
Overall market sales
McKesson Corporation is one of the largest pharmaceutical distributors in the United States. The company is a key link in the supply chain, delivering medications from manufacturers to pharmacies and hospitals. This overall economic activity impacts McKesson through overall healthcare spending. Population growth and increased access to healthcare are increasing supply volumes.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company McKesson Corporation
McKesson is one of the largest pharmaceutical distributors in the US, supplying pharmacies and hospitals. The company's revenue depends on the volume and prices of prescription drugs. This chart shows analysts' expectations for rising healthcare costs in the US, particularly in the prescription drug segment, which directly impacts McKesson's business.
Future (projected) sales of companies in the market segment - Pharmacy
McKesson Corporation is a leading distributor of pharmaceuticals, medical supplies, and healthcare IT solutions in the United States. This chart shows projected revenues for the entire drug distribution sector. It reflects expectations for rising prescription drug spending, which directly impacts the volumes flowing through the McKesson network.
Future (projected) sales of the market as a whole
McKesson Corporation is one of the largest pharmaceutical distributors in the United States. Its business involves logistics and deliveries of medications from manufacturers to pharmacies and hospitals. This business is stable, as demand for medications is inelastic. However, this schedule, reflecting the overall state of the economy, affects the volume of elective medical procedures and the overall financial health of its clientsโhospitals and pharmacies.
Marginality of the company, segment and market as a whole
Company marginality McKesson Corporation
McKesson Corporation is one of the "big three" pharmaceutical distributors in the US, supplying pharmacies and hospitals with medications. This chart shows a business with huge turnover but very low margins. The company's efficiency depends on its ability to manage logistics and working capital with pinpoint precision.
Market segment marginality - Pharmacy
McKesson Corporation is one of the "big three" pharmaceutical distributors in the United States. The company is a key link between drug manufacturers and pharmacies, handling very high volumes but with low margins. This chart shows how its scale and logistical efficiency enable the company to be profitable in a segment with extremely low margins.
Market marginality as a whole
McKesson Corporation is one of the largest pharmaceutical distributors in the US and a provider of medical IT solutions. This chart shows overall profitability. It illustrates McKesson as a business with huge revenues but very low margins. Profitability in distribution depends on scale and maximum operational efficiency.
Employees in the company, segment and market as a whole
Number of employees in the company McKesson Corporation
McKesson Corporation is one of the largest distributors of pharmaceuticals and medical supplies in the United States, as well as a provider of healthcare IT solutions. This chart shows the massive team that maintains this vital supply chain. The staff dynamics reflect overall trends in American healthcare and consolidation within the sector.
Share of the company's employees McKesson Corporation within the market segment - Pharmacy
This chart illustrates McKesson Corporation's key role in the US healthcare system. As one of the "Big Three" distributors, it supplies drugs and medical supplies to pharmacies and hospitals. Its vast share of employees in the sector reflects the scale of its logistics network, which is a vital artery ensuring access to medications nationwide.
Number of employees in the market segment - Pharmacy
McKesson Corporation is one of the "big three" pharmaceutical distributors in the United States. The company is a critical link in the drug supply chain from manufacturers to pharmacies and hospitals. This logistics business requires a huge staff. This chart illustrates the scale of this "invisible" part of the healthcare system, where McKesson is a key player.
Number of employees in the market as a whole
McKesson (MCK) is one of the "big three" pharmaceutical distributors in the US. They are a critical but low-margin "middleman" between drugmakers (Pfizer) and pharmacies (CVS). This graph reflects the scale of healthcare. The entire economy needs medications, and McKesson provides the logistics to get these drugs to patients.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company McKesson Corporation (MCK)
McKesson is one of the "big three" pharmaceutical distributors in the US. It's a business with huge revenues but low profit margins. This chart reflects its critical role in the healthcare supply chain and the efficiency of its massive logistics network.
Market capitalization per employee (in thousands of dollars) in the market segment - Pharmacy
McKesson (MCK) is one of the "big three" drug distributors. It's a critically important but incredibly low-margin business, relying on volume and logistical efficiency. This chart shows the market cost per employee in this "scale" operating model, where every cent counts.
Market capitalization per employee (in thousands of dollars) for the overall market
McKesson Corporation is one of the largest pharmaceutical distributors in the US and a provider of medical IT solutions. This chart illustrates the specifics of the distribution business: huge turnover but low margins. The employee rating here reflects logistics efficiency and the ability to manage massive product flows.
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company McKesson Corporation (MCK)
McKesson (MCK) is one of the "big three" wholesale drug distributors in the US (along with AmerisourceBergen and Cardinal Health). They act as intermediaries between pharmaceutical companies and pharmacies. It's a business with huge turnover but very low margins. This chart shows logistics efficiency. Profit margins are measured in fractions of a percent, so maximum automation is essential.
Profit per employee (in thousands of dollars) in the market segment - Pharmacy
McKesson (MCK) is a wholesale drug distributor. This chart shows the benchmark for "Pharmacy" (Distribution). In this sector, labor profitability is very low. This is a business with enormous turnover but tiny margins (a fraction of a percent). The benchmark shows logistics efficiency: who can deliver a pill faster and cheaper.
Profit per employee (in thousands of dollars) for the market as a whole
McKesson Corporation is one of the largest pharmaceutical distributors in the United States. The company is a key link in the drug supply chain from manufacturers to pharmacies and hospitals. This chart demonstrates the efficiency of its staff in a logistics business with huge turnover but traditionally low margins.
Sales to employees of the company, segment and market as a whole
Sales per company employee McKesson Corporation (MCK)
McKesson is one of the largest pharmaceutical distributors in the US. This chart demonstrates the efficiency of its logistics business, which has high turnover but low margins. The company is a key link between drug manufacturers and pharmacies, and its high revenue per employee is a result of its huge supply volumes.
Sales per employee in the market segment - Pharmacy
McKesson is one of the "big three" pharmaceutical distributors in the US, serving as a link between drug manufacturers and pharmacies. This chart shows the average revenue per employee in the segment. In this low-margin, high-volume business, this is an important indicator of logistics efficiency compared to competitors.
Sales per employee for the market as a whole
McKesson is one of the "big three" wholesale drug distributors in the US (along with AmerisourceBergen and Cardinal Health). They act as intermediaries between drug manufacturers (Pfizer) and pharmacies (CVS). It's a business with huge turnover but very low margins. This chart shows the enormous volume of revenue that passes through their warehouses per employee.
Short shares by company, segment and market as a whole
Shares shorted by company McKesson Corporation (MCK)
McKesson is one of the "big three" pharmaceutical distributors in the US, also providing IT solutions for pharmacies. The bearish sentiment seen in this chart may be related to regulatory risks (opioid lawsuits) and the extremely low profitability of the distribution business, which is vulnerable to any price pressure.
Shares shorted by market segment - Pharmacy
McKesson is one of the "big three" drug distributors in the US. The company is a critical link between manufacturers (Pfizer) and pharmacies (CVS). This chart shows the overall sentiment in the sector. It reflects investor concerns about pressure on distributor margins or regulatory risks (such as the opioid crisis).
Shares shorted by the overall market
McKesson is one of the "big three" drug distributors in the US, a key logistics link between pharmaceutical companies and pharmacies. It's a business with low margins but huge and stable revenue. This chart reflects the general fear. When it rises, investors value McKesson's predictability, because people need medications every day, regardless of the crisis.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator McKesson Corporation (MCK)
McKesson (MCK) is one of the "big three" drug distributors in the US. The business operates on razor-thin margins but at enormous volumes. This chart measures momentum. "Oversold" (below 30) often reflects panic over legal risks (such as opioid lawsuits) or fear of regulatory pressure on prices. "Overbought" (above 70) signals optimism about cash flow stability.
RSI 14 Market Segment - Pharmacy
McKesson (MCK) is one of the "Big Three" drug distributors in the US. They are a critical, yet low-margin, link between drug manufacturers and pharmacies. This indicator shows the "temperature" of the healthcare sector. It helps understand: is MCK growing due to its operational efficiency or is the entire sector oversold due to regulatory pressure?
RSI 14 for the overall market
McKesson is one of the "big three" drug distributors in the US. It's a giant "logistics pipeline" that delivers medications to pharmacies and hospitals. Their margins are low, but their turnover is colossal. This market sentiment curve has little impact on demand: people get sick in both euphoria and panic. This makes McKesson a classic "defense" business.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast MCK (McKesson Corporation)
This chart shows the collective opinion on McKesson, one of the "big three" drug distributors. Their target prices are driven by rising prices for brand-name drugs and the volume of government programs (like Medicare). The consensus is that this "boring" but critical logistics business will ensure steady, albeit slow, growth.
The difference between the consensus estimate and the actual stock price MCK (McKesson Corporation)
McKesson is one of the big three drug distributors in the US. They are a critical link between drug manufacturers and pharmacies/hospitals. This chart shows how analysts assess their operational efficiency and role in distributing specialized (oncology) drugs. It reflects the gap between the target price and the current price.
Analyst consensus forecast for stock prices by market segment - Pharmacy
McKesson is one of the "big three" drug distributors in the US, supplying pharmacies and hospitals. It's a low-margin but large-scale business. This chart shows analysts' general expectations for the drug distribution sector. It reflects whether experts see stability in healthcare supply chains or pricing pressure.
Analysts' consensus forecast for the overall market share price
McKesson (MCK) is one of the big three drug distributors in the US. They are a vital link between manufacturers (Pfizer) and pharmacies (CVS). It's a low-margin, high-volume business. This market sentiment chart is important. While drug demand is stable, market optimism makes it easier for McKesson to manage debt and finance M&A.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index McKesson Corporation
McKesson is one of the big three drug distributors in the US. It's a gigantic but low-margin business, serving as a critical intermediary between drug manufacturers and pharmacies. This chart is an indicator of the size of the US healthcare system. It's not about margins, but about the enormous turnover, reflecting the total number of prescriptions processed through the American healthcare system.
AKIMA Market Segment Index - Pharmacy
McKesson Corporation is one of the big three drug distributors in the US, serving as a vital link between pharmaceutical manufacturers and pharmacies/hospitals. This aggregate metric evaluates companies. The chart shows the sector average. This benchmark: how does McKesson's scale in healthcare logistics differentiate it from the average competitor?
The AKIM Index for the overall market
McKesson is one of the big three drug distributors in the US. The company is a vital, yet low-margin, intermediary between drug manufacturers and pharmacies/hospitals. This chart, which reflects the market average, provides context. It helps assess how this logistics giant, operating in the stable healthcare sector, compares to the overall macroeconomic fluctuations reflected by this indicator.